# OSTM1

## Overview
The OSTM1 gene encodes the osteoclastogenesis associated transmembrane protein 1, a type I transmembrane protein that plays a pivotal role in lysosomal function and intracellular trafficking. This protein is integral to the stability and function of the ClC-7 chloride/proton exchanger, acting as a β-subunit that is essential for ClC-7's ion transport activity and proper localization within lysosomes. OSTM1 is characterized by its heavily glycosylated structure, which includes a luminal domain that forms a protective cap over ClC-7, preventing its degradation by lysosomal proteases. The protein's interactions with kinesin motor proteins, particularly KIF5B, facilitate the transport of cellular cargos along microtubules, which is crucial for bone resorption and neuronal health. Mutations in the OSTM1 gene are linked to severe forms of autosomal recessive osteopetrosis, underscoring its clinical significance in bone density regulation and neurological function (Ott2013Severe; Pandruvada2016Role; Schrecker2020CryoEM).

## Structure
OSTM1 is a single-pass transmembrane protein with a heavily glycosylated N-terminal domain and a short cytosolic C-terminal region (Zhang2023Structure). The luminal domain of OSTM1 consists of two three-helix bundles connected by disulfide bonds, forming a large dimer interface that is stabilized by hydrophobic and polar interactions, such as an ionic interaction between Arg107 and Asp150 (Schrecker2020CryoEM). This domain is further stabilized by three pairs of disulfide bonds within a single OSTM1 monomer, which are conserved across species (Zhang2020Molecular).

OSTM1 is highly glycosylated, with glycosylation modifications observed on several asparagine residues, including Asn 93, Asn 128, Asn 163, Asn 184, Asn 194, Asn 216, and Asn 263 (Zhang2020Molecular). These glycosylations likely protect the protein from the lysosomal environment (Schrecker2020CryoEM). The glycosylated N-terminal domain forms a dimer in the lysosomal lumen, positioned atop the dimeric CLC-7, while its transmembrane helix tightly packs with the transmembrane domain of CLC-7 (Zhang2023Structure). OSTM1 acts as a protective cap over CLC-7, preventing degradation by lysosomal proteases (Zhang2020Molecular).

## Function
The OSTM1 gene encodes a type I transmembrane protein that plays a critical role in intracellular trafficking and lysosomal function. In healthy human cells, OSTM1 is involved in the dispersion and trafficking of cellular cargos from the endoplasmic reticulum to late endosomal/lysosomal compartments. This process is essential for bone resorption and neuronal health, as OSTM1 interacts with kinesin motor proteins, particularly KIF5B, to facilitate the transport of cellular cargos along microtubules (Pandruvada2016Role).

OSTM1 is also crucial for the function of the ClC-7 chloride/proton exchanger, acting as a β-subunit necessary for its ion transport activity. The interaction between OSTM1 and ClC-7 stabilizes ClC-7 and is essential for its proper localization and function in lysosomes, which is vital for maintaining bone density and preventing osteopetrosis (Lange2006ClC7; Leisle2011ClC7).

The protein is highly N-glycosylated and undergoes posttranslational processing, which affects its trafficking within the cell. OSTM1 is primarily localized in the endoplasmic reticulum, trans-Golgi network, and endosomes/lysosomes, where it participates in protein sorting and transport within the endomembrane system (Pandruvada2016Role).

## Clinical Significance
Mutations in the OSTM1 gene are associated with a severe form of autosomal recessive osteopetrosis (ARO), characterized by osteoclast dysfunction leading to increased bone density and significant neurological involvement. This condition, known as neuronopathic infantile malignant osteopetrosis, presents with symptoms such as congenital brain atrophy, myelination defects, retinal degeneration, and a rapid fatal course, often resulting in death within the first few years of life (Pangrazio2006Mutations; Ott2013Severe). Patients with OSTM1 mutations may experience severe central nervous system symptoms, including cerebral atrophy, seizures, blindness, and deafness (Maranda2008Clinical; Ott2013Severe).

The OSTM1 gene encodes a glycoprotein that interacts with the ClC-7 protein, crucial for osteoclast acid secretion and bone resorption. Mutations in OSTM1 can disrupt this interaction, leading to impaired bone resorption and lysosomal function (Lange2006ClC7). The severe phenotype associated with OSTM1 mutations is due to both skeletal and neurological defects, as evidenced by studies in both human patients and mouse models (Pandruvada2016Role; Pata2018Ostm1). Early genetic diagnosis is critical for prognosis and potential treatment options, although some forms of osteopetrosis cannot be cured by hematopoietic stem cell transplantation due to neuronal involvement (Ott2013Severe).

## Interactions
OSTM1 interacts with the chloride-proton exchanger ClC-7, forming a complex essential for lysosomal function and bone resorption. This interaction is crucial for the stability and activity of ClC-7, as OSTM1 acts as a β-subunit, protecting ClC-7 from degradation and ensuring its proper localization to lysosomes (Schrecker2020CryoEM; Lange2006ClC7). The transmembrane domains of OSTM1 and ClC-7 mediate their interaction, with specific residues forming hydrogen bonds and hydrophobic interactions that are vital for the complex's stability and function (Schrecker2020CryoEM; Zhang2020Molecular).

OSTM1 also interacts with kinesin motor protein KIF5B, which is involved in intracellular transport along microtubules. This interaction is specific to the heavy chains of KIF5B and is essential for the intracellular trafficking and dispersion of OSTM1 (Pandruvada2016Role). The cytosolic C-terminal domain of OSTM1 is crucial for its interaction with KIF5B, and mutations in this domain can disrupt the interaction (Pandruvada2016Role). These interactions suggest that OSTM1 plays a role in the intracellular trafficking of proteins and may be part of a multifunctional protein platform involved in nucleocytoplasmic transport (Pandruvada2016Role).


## References


[1. (Schrecker2020CryoEM) Marina Schrecker, Julia Korobenko, and Richard K Hite. Cryo-em structure of the lysosomal chloride-proton exchanger clc-7 in complex with ostm1. eLife, August 2020. URL: http://dx.doi.org/10.7554/elife.59555, doi:10.7554/elife.59555. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.59555)

[2. (Zhang2020Molecular) Sensen Zhang, Yang Liu, Bing Zhang, Jun Zhou, Tianyu Li, Zhiqiang Liu, Yang Li, and Maojun Yang. Molecular insights into the human clc-7/ostm1 transporter. Science Advances, August 2020. URL: http://dx.doi.org/10.1126/sciadv.abb4747, doi:10.1126/sciadv.abb4747. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.abb4747)

[3. (Lange2006ClC7) Philipp F. Lange, Lena Wartosch, Thomas J. Jentsch, and Jens C. Fuhrmann. Clc-7 requires ostm1 as a β-subunit to support bone resorption and lysosomal function. Nature, 440(7081):220–223, March 2006. URL: http://dx.doi.org/10.1038/nature04535, doi:10.1038/nature04535. This article has 291 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature04535)

[4. (Ott2013Severe) Claus-Eric Ott, Björn Fischer, Phillipe Schröter, Reyk Richter, Neerja Gupta, Nishant Verma, Madhulika Kabra, Stefan Mundlos, Anna Rajab, Heidemarie Neitzel, and Uwe Kornak. Severe neuronopathic autosomal recessive osteopetrosis due to homozygous deletions affecting ostm1. Bone, 55(2):292–297, August 2013. URL: http://dx.doi.org/10.1016/j.bone.2013.04.007, doi:10.1016/j.bone.2013.04.007. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2013.04.007)

[5. (Pandruvada2016Role) Subramanya N. M. Pandruvada, Janie Beauregard, Suzanne Benjannet, Monica Pata, Claude Lazure, Nabil G. Seidah, and Jean Vacher. Role of ostm1 cytosolic complex with kinesin 5b in intracellular dispersion and trafficking. Molecular and Cellular Biology, 36(3):507–521, February 2016. URL: http://dx.doi.org/10.1128/MCB.00656-15, doi:10.1128/mcb.00656-15. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00656-15)

[6. (Leisle2011ClC7) Lilia Leisle, Carmen F Ludwig, Florian A Wagner, Thomas J Jentsch, and Tobias Stauber. Clc-7 is a slowly voltage-gated 2cl−/1h+-exchanger and requires ostm1 for transport activity: slowly voltage-gated 2cl/h-exchange by clc-7/ostm1. The EMBO Journal, 30(11):2140–2152, April 2011. URL: http://dx.doi.org/10.1038/emboj.2011.137, doi:10.1038/emboj.2011.137. This article has 184 citations.](https://doi.org/10.1038/emboj.2011.137)

[7. (Maranda2008Clinical) Bruno Maranda, Gilles Chabot, Jean-Claude Décarie, Monica Pata, Bouziane Azeddine, Alain Moreau, and Jean Vacher. Clinical and cellular manifestations of ostm1-related infantile osteopetrosis. Journal of Bone and Mineral Research, 23(2):296–300, February 2008. URL: http://dx.doi.org/10.1359/jbmr.071015, doi:10.1359/jbmr.071015. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1359/jbmr.071015)

[8. (Pangrazio2006Mutations) Alessandra Pangrazio, Pietro Luigi Poliani, André Megarbane, Gérard Lefranc, Edoardo Lanino, Maja Di Rocco, Francesca Rucci, Franco Lucchini, Maria Ravanini, Fabio Facchetti, Mario Abinun, Paolo Vezzoni, Anna Villa, and Annalisa Frattini. Mutations in ostm1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. Journal of Bone and Mineral Research, 21(7):1098–1105, July 2006. URL: http://dx.doi.org/10.1359/jbmr.060403, doi:10.1359/jbmr.060403. This article has 90 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1359/jbmr.060403)

[9. (Zhang2023Structure) Zhixuan Zhang, Long Chen, Jin He, and Ji She. Structure of the human clc-7/ostm1 complex reveals a novel state. JUSTC, 53(3):0306, 2023. URL: http://dx.doi.org/10.52396/justc-2022-0172, doi:10.52396/justc-2022-0172. This article has 0 citations.](https://doi.org/10.52396/justc-2022-0172)

[10. (Pata2018Ostm1) Monica Pata and Jean Vacher. Ostm1 bifunctional roles in osteoclast maturation: insights from a mouse model mimicking a human ostm1 mutation. Journal of Bone and Mineral Research, 33(5):888–898, January 2018. URL: http://dx.doi.org/10.1002/jbmr.3378, doi:10.1002/jbmr.3378. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/jbmr.3378)